AlexandersonB (1972a) Pharmacokinetics of nortriptyline in man after single and multiple oral doses. The predictability of steady-state plasma concentrations from single dose plasma level data. European Journal of Clinical Pharmacology4, 82.
2.
AlexandersonB (1972b) Pharmacokinetics of desmethylimipramine and nortriptyline in man after single dose and multiple oral doses: A cross-over study. European Journal of Clinical Pharmacology5, 1.
3.
BraithwaiteR AGouldingRTheanoJBaileyJCoppenA (1972) Plasma concentration of Amitriptyline and clinical response. The Lancet1, 1297.
4.
BurrowsG DDaviesBScrogginsB A (1972) Plasma concentration of nortriptyline and clinical response in depressive illness. The Lancet2, 619.
5.
CurryS HDavisJ MJanowskyD SMarshallJ H L (1970) Factors affecting chlorpromazine plasma levels in psychiatric patients. Archives of General Psychiatry22, 209.
6.
HermannB (1969) Personal communication.
7.
Kragh-SørensenPÅsbergMEggert-HansenC (1973) Plasma-nortriptyline levels in endogenous depression. The Lancet1, 113.
8.
MoodyJ PTaitA CTodrickA (1967) Plasma levels of imipramine and desmethylimipramine during therapy. British Journal of Psychiatry113, 183.
9.
MoodyJ PWhyteS FNaylorG J (1973) A simple method for the determination of protriptyline in plasma. Clinical Chimica Acta43, 355.
10.
NotaraR E (1971) Biopharmaceutics and Pharmacokinetics, Dekker, New York, p 4.
11.
SjöqvistFHammerWIdestromC MLindMTuckDAsbergM (1968) Plasma level of monomethylated tricyclic antidepressants and side effects in man. Proceedings of the European Society for Study of Drug Toxicity Paris 1967. International Congress Series Number 145 Excerpta Medica, Amsterdam.
12.
StevensonI HBallingerB RPreslyAReidA H (To be published).
13.
WalterC J S (1971) Drug plasma levels and clinical effect. Proceedings of the Royal Society of Medicine64, 282.
14.
ZeidenbergPPerelJ MKanzlerMWhartonR NMalitzS (1971) Clinical and metabolic studies with imipramine in man. American Journal of Psychiatry127, 1321.
